Recruitment/Posting Title Pediatric Basic Cancer Research, Tenure Track (Assistant/Associate Prof) Department Cancer Institute of New Jersey Salary Commensurate With Experience Posting Summary Rutgers Cancer Institute of New Jersey seeks investigators with research relevant to pediatric cancer or blood disorders to apply for Assistant to Professor, tenure-track faculty positions. Preference will be given to research that relates to the following fields: stem cell biology and transplantation; cellular therapies; immunotherapeutics; cancer predisposition syndromes; or gene therapies. However, candidates with experience in any research field related to the prevention, diagnosis, treatment, or basic biology of cancers and blood disorders affecting children and adolescents are encouraged to apply. Academic rank will be through the Rutgers Robert Wood Johnson Medical School and is commensurate with qualifications and experience.The successful applicant will be expected to develop and maintain an innovative, independent, collaborative, and extramurally-funded research program. The Pediatric Hematology/Oncology Program provides comprehensive, state-of-the-art care for children and adolescents with cancer and blood disorders and is a member of the National Cancer Institute supported Children’s Oncology Group (COG), the world’s largest organization devoted exclusively to childhood and adolescent cancer research and clinical trials. The LITE Program at Rutgers Cancer Institute of New Jersey provides long-term evaluation, support, and health education for the growing population of childhood cancer survivors.

The New Jersey Pediatric Hematology/Oncology Research Center of Excellence (NJ PHORCE) was established in 2021 is led by Dr. Peter Cole, the Embrace Kids Endowed Chair and Professor of Pediatric Hematology and Oncology. Its mission is to improve the lives of children diagnosed with cancer or blood disorders through research, training and education, community engagement, and public policy advocacy. To highlight just a few examples, current members of the Center are at the forefront of their research fields: in the biology of DNA repair; in the development of innovative targeted therapies; in preventing treatment-related toxicities; and in understanding disparities in treatment outcomes. Visit us at https://www.cinj.org/research/nj-pediatric-hematology-and-oncology-research-center-excellence-nj-phorce.

NJ PHORCE is based in the Rutgers Cancer Institute, New Jersey’s only NCI designated comprehensive cancer center.
Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state’s largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials. Visit www.cinj.org.

Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise.

For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at cinjcareers@cinj.rutgers.edu.

See all our open faculty positions here! Position Status Full Time Posting Number 23FA0916 Posting Open Date 08/01/2023 Posting Close Date